Page last updated: 2024-09-03

dx 9065 and ym 60828

dx 9065 has been researched along with ym 60828 in 3 studies

Compound Research Comparison

Studies (dx 9065)	Trials (dx 9065)	Recent Studies (post-2010) (dx 9065)	Studies (ym 60828)	Trials (ym 60828)	Recent Studies (post-2010) (ym 60828)
17	0	0	27	0	2

Protein Interaction Comparison

Protein	Taxonomy	ym 60828 (IC50)
Coagulation factor X	Mus musculus (house mouse)	0.006
Prothrombin	Homo sapiens (human)	0.0077
Coagulation factor X	Homo sapiens (human)	0.002
Anionic trypsin-2	Rattus norvegicus (Norway rat)	0.063

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abbenante, G; Fairlie, DP; Leung, D	1
Brady, L; Jones, SD; Liebeschuetz, JW; Mahler, J; Martin, H; Morgan, PJ; Murray, CW; Rimmer, AD; Roscoe, JM; Waszkowycz, B; Welsh, PM; Wilkinson, K; Wylie, WA; Young, SC	1
Cheney, DL; Knabb, RM; Pinto, DJ; Smallheer, JM; Wexler, RR	1

Reviews

2 review(s) available for dx 9065 and ym 60828

Article	Year
Protease inhibitors: current status and future prospects. Journal of medicinal chemistry, 2000, Feb-10, Volume: 43, Issue:3 Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors	2000
Factor Xa inhibitors: next-generation antithrombotic agents. Journal of medicinal chemistry, 2010, Sep-09, Volume: 53, Issue:17 Topics: Administration, Oral; Animals; Anticoagulants; Biological Availability; Clinical Trials as Topic; Drug Design; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Hemostasis; Humans; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Thrombosis	2010

Article

Year

Protease inhibitors: current status and future prospects.

Journal of medicinal chemistry, 2000, Feb-10, Volume: 43, Issue:3

Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors

2000

Factor Xa inhibitors: next-generation antithrombotic agents.

Journal of medicinal chemistry, 2010, Sep-09, Volume: 53, Issue:17

Topics: Administration, Oral; Animals; Anticoagulants; Biological Availability; Clinical Trials as Topic; Drug Design; Drug Evaluation, Preclinical; Factor Xa Inhibitors; Hemostasis; Humans; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Thrombosis

2010

Other Studies

1 other study(ies) available for dx 9065 and ym 60828

Article	Year
PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors. Journal of medicinal chemistry, 2002, Mar-14, Volume: 45, Issue:6 Topics: Animals; Benzamidines; Combinatorial Chemistry Techniques; Drug Design; Enzyme Inhibitors; Factor Xa Inhibitors; Humans; Models, Molecular; Protein Conformation; Rats; Structure-Activity Relationship	2002

Article

Year

PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors.

Journal of medicinal chemistry, 2002, Mar-14, Volume: 45, Issue:6

Topics: Animals; Benzamidines; Combinatorial Chemistry Techniques; Drug Design; Enzyme Inhibitors; Factor Xa Inhibitors; Humans; Models, Molecular; Protein Conformation; Rats; Structure-Activity Relationship

2002